nodes	percent_of_prediction	percent_of_DWPC	metapath
Xylometazoline—ADRA1B—GPCR downstream signaling—PIK3CA—lung cancer	0.000126	0.000126	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—EP300—lung cancer	0.000126	0.000126	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PIK3CD—lung cancer	0.000126	0.000126	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—SRC—lung cancer	0.000125	0.000125	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—KRAS—lung cancer	0.000125	0.000125	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—PIK3CA—lung cancer	0.000125	0.000125	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—AKT1—lung cancer	0.000124	0.000124	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—MDM2—lung cancer	0.000124	0.000124	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—ALB—lung cancer	0.000124	0.000124	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—RAF1—lung cancer	0.000124	0.000124	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—MAPK3—lung cancer	0.000123	0.000123	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CASP3—lung cancer	0.000123	0.000123	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—IL2—lung cancer	0.000123	0.000123	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—SRC—lung cancer	0.000123	0.000123	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—POMC—lung cancer	0.000123	0.000123	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—ERBB2—lung cancer	0.000122	0.000122	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—IL6—lung cancer	0.000122	0.000122	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—VEGFA—lung cancer	0.000122	0.000122	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—BRAF—lung cancer	0.000121	0.000121	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—STAT3—lung cancer	0.000121	0.000121	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—PIK3CB—lung cancer	0.000121	0.000121	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—MTOR—lung cancer	0.000121	0.000121	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—NRAS—lung cancer	0.000121	0.000121	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CCND1—lung cancer	0.00012	0.00012	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—APC—lung cancer	0.00012	0.00012	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PIK3CG—lung cancer	0.00012	0.00012	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—KIT—lung cancer	0.00012	0.00012	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—NRAS—lung cancer	0.00012	0.00012	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—IL6R—lung cancer	0.00012	0.00012	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—JUN—lung cancer	0.00012	0.00012	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—VEGFA—lung cancer	0.00012	0.00012	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CREBBP—lung cancer	0.000119	0.000119	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—STAT3—lung cancer	0.000118	0.000118	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—EGF—lung cancer	0.000118	0.000118	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—NRAS—lung cancer	0.000118	0.000118	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—EGFR—lung cancer	0.000117	0.000117	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—PTEN—lung cancer	0.000117	0.000117	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—PIK3CA—lung cancer	0.000116	0.000116	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—MMP9—lung cancer	0.000116	0.000116	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CXCL8—lung cancer	0.000116	0.000116	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—MDM2—lung cancer	0.000116	0.000116	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CDKN1A—lung cancer	0.000116	0.000116	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—PTEN—lung cancer	0.000116	0.000116	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—RAF1—lung cancer	0.000116	0.000116	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—MAPK3—lung cancer	0.000115	0.000115	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—HRAS—lung cancer	0.000115	0.000115	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—PIK3CA—lung cancer	0.000115	0.000115	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—MAPK3—lung cancer	0.000115	0.000115	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—ERBB2—lung cancer	0.000114	0.000114	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—MDM2—lung cancer	0.000114	0.000114	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—MAP2K1—lung cancer	0.000114	0.000114	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—POMC—lung cancer	0.000114	0.000114	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—RAF1—lung cancer	0.000114	0.000114	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PIK3CD—lung cancer	0.000113	0.000113	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—MAPK3—lung cancer	0.000113	0.000113	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—PIK3CB—lung cancer	0.000113	0.000113	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—MTOR—lung cancer	0.000113	0.000113	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—AKT1—lung cancer	0.000113	0.000113	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—ERBB2—lung cancer	0.000113	0.000113	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—BRAF—lung cancer	0.000112	0.000112	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—MYC—lung cancer	0.000112	0.000112	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—AKT1—lung cancer	0.000112	0.000112	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—PIK3CA—lung cancer	0.000112	0.000112	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—EP300—lung cancer	0.000111	0.000111	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CASP3—lung cancer	0.000111	0.000111	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—IL6R—lung cancer	0.000111	0.000111	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—PIK3CB—lung cancer	0.000111	0.000111	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—MTOR—lung cancer	0.000111	0.000111	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—IL2—lung cancer	0.000111	0.000111	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CREBBP—lung cancer	0.000111	0.000111	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—KRAS—lung cancer	0.000111	0.000111	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—IL6—lung cancer	0.00011	0.00011	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—EP300—lung cancer	0.00011	0.00011	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—MYC—lung cancer	0.00011	0.00011	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—EGFR—lung cancer	0.00011	0.00011	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PIK3CB—lung cancer	0.00011	0.00011	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—EGFR—lung cancer	0.000109	0.000109	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PTGS2—lung cancer	0.000109	0.000109	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CXCL8—lung cancer	0.000108	0.000108	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CCND1—lung cancer	0.000108	0.000108	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—JUN—lung cancer	0.000108	0.000108	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—HRAS—lung cancer	0.000108	0.000108	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—EGFR—lung cancer	0.000108	0.000108	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—SRC—lung cancer	0.000107	0.000107	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CXCL8—lung cancer	0.000107	0.000107	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—HRAS—lung cancer	0.000106	0.000106	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—MAP2K1—lung cancer	0.000106	0.000106	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PIK3CD—lung cancer	0.000105	0.000105	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—MMP9—lung cancer	0.000105	0.000105	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—AKT1—lung cancer	0.000105	0.000105	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CDKN1A—lung cancer	0.000105	0.000105	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—VEGFA—lung cancer	0.000104	0.000104	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—PTEN—lung cancer	0.000104	0.000104	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—PIK3CA—lung cancer	0.000104	0.000104	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CASP3—lung cancer	0.000104	0.000104	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—KRAS—lung cancer	0.000104	0.000104	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—IL2—lung cancer	0.000104	0.000104	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—STAT3—lung cancer	0.000103	0.000103	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—NRAS—lung cancer	0.000103	0.000103	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—IL6—lung cancer	0.000103	0.000103	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—AKT1—lung cancer	0.000103	0.000103	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—KRAS—lung cancer	0.000103	0.000103	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CASP3—lung cancer	0.000102	0.000102	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—IL2—lung cancer	0.000102	0.000102	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—AKT1—lung cancer	0.000102	0.000102	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—PIK3CA—lung cancer	0.000102	0.000102	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—KRAS—lung cancer	0.000102	0.000102	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—IL6—lung cancer	0.000102	0.000102	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—MDM2—lung cancer	0.000101	0.000101	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—RAF1—lung cancer	0.000101	0.000101	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CCND1—lung cancer	0.000101	0.000101	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—JUN—lung cancer	0.000101	0.000101	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—ERBB2—lung cancer	0.0001	0.0001	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—EP300—lung cancer	9.96e-05	9.96e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CCND1—lung cancer	9.95e-05	9.95e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—JUN—lung cancer	9.92e-05	9.92e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—MAPK3—lung cancer	9.88e-05	9.88e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PIK3CB—lung cancer	9.87e-05	9.87e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—MTOR—lung cancer	9.87e-05	9.87e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—MMP9—lung cancer	9.81e-05	9.81e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CDKN1A—lung cancer	9.78e-05	9.78e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—PTEN—lung cancer	9.75e-05	9.75e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—SRC—lung cancer	9.68e-05	9.68e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—MMP9—lung cancer	9.66e-05	9.66e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CDKN1A—lung cancer	9.62e-05	9.62e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—MYC—lung cancer	9.61e-05	9.61e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—PTEN—lung cancer	9.6e-05	9.6e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—PIK3CA—lung cancer	9.53e-05	9.53e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—AKT1—lung cancer	9.52e-05	9.52e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CXCL8—lung cancer	9.48e-05	9.48e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PTEN—lung cancer	9.47e-05	9.47e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—PIK3CA—lung cancer	9.46e-05	9.46e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—VEGFA—lung cancer	9.43e-05	9.43e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—MDM2—lung cancer	9.42e-05	9.42e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—HRAS—lung cancer	9.42e-05	9.42e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—EGFR—lung cancer	9.4e-05	9.4e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—RAF1—lung cancer	9.39e-05	9.39e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—AKT1—lung cancer	9.37e-05	9.37e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—STAT3—lung cancer	9.34e-05	9.34e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—PIK3CA—lung cancer	9.33e-05	9.33e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—NRAS—lung cancer	9.32e-05	9.32e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—EP300—lung cancer	9.3e-05	9.3e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—ERBB2—lung cancer	9.29e-05	9.29e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—TP53—lung cancer	9.22e-05	9.22e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—MTOR—lung cancer	9.17e-05	9.17e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PIK3CB—lung cancer	9.17e-05	9.17e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—AKT1—lung cancer	9.16e-05	9.16e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—EP300—lung cancer	9.15e-05	9.15e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CASP3—lung cancer	9.08e-05	9.08e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—IL2—lung cancer	9.06e-05	9.06e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—SRC—lung cancer	9.05e-05	9.05e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—EP300—lung cancer	9.04e-05	9.04e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—TP53—lung cancer	9.03e-05	9.03e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—IL6—lung cancer	9.02e-05	9.02e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—MAPK3—lung cancer	8.92e-05	8.92e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—SRC—lung cancer	8.9e-05	8.9e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—KRAS—lung cancer	8.88e-05	8.88e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CCND1—lung cancer	8.83e-05	8.83e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—HRAS—lung cancer	8.82e-05	8.82e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—JUN—lung cancer	8.82e-05	8.82e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CXCL8—lung cancer	8.81e-05	8.81e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—VEGFA—lung cancer	8.81e-05	8.81e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—HRAS—lung cancer	8.75e-05	8.75e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—STAT3—lung cancer	8.72e-05	8.72e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—NRAS—lung cancer	8.7e-05	8.7e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—MYC—lung cancer	8.68e-05	8.68e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—VEGFA—lung cancer	8.67e-05	8.67e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—HRAS—lung cancer	8.64e-05	8.64e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—STAT3—lung cancer	8.59e-05	8.59e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—MMP9—lung cancer	8.58e-05	8.58e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—NRAS—lung cancer	8.56e-05	8.56e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CDKN1A—lung cancer	8.55e-05	8.55e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PTEN—lung cancer	8.53e-05	8.53e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—AKT1—lung cancer	8.51e-05	8.51e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—EGFR—lung cancer	8.49e-05	8.49e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—IL6—lung cancer	8.44e-05	8.44e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CASP3—lung cancer	8.43e-05	8.43e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—IL2—lung cancer	8.42e-05	8.42e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—IL6—lung cancer	8.38e-05	8.38e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—MAPK3—lung cancer	8.33e-05	8.33e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—AKT1—lung cancer	8.32e-05	8.32e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—IL6—lung cancer	8.27e-05	8.27e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—PIK3CA—lung cancer	8.23e-05	8.23e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CCND1—lung cancer	8.21e-05	8.21e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—MAPK3—lung cancer	8.2e-05	8.2e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—JUN—lung cancer	8.19e-05	8.19e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—PIK3CA—lung cancer	8.16e-05	8.16e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—EP300—lung cancer	8.13e-05	8.13e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—MYC—lung cancer	8.11e-05	8.11e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—KRAS—lung cancer	8.02e-05	8.02e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—MYC—lung cancer	7.98e-05	7.98e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—MMP9—lung cancer	7.97e-05	7.97e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CDKN1A—lung cancer	7.94e-05	7.94e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—EGFR—lung cancer	7.93e-05	7.93e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PTEN—lung cancer	7.92e-05	7.92e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—SRC—lung cancer	7.91e-05	7.91e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—TP53—lung cancer	7.89e-05	7.89e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—EGFR—lung cancer	7.8e-05	7.8e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—AKT1—lung cancer	7.79e-05	7.79e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—AKT1—lung cancer	7.73e-05	7.73e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—VEGFA—lung cancer	7.7e-05	7.7e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—AKT1—lung cancer	7.63e-05	7.63e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—STAT3—lung cancer	7.63e-05	7.63e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—NRAS—lung cancer	7.61e-05	7.61e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—EP300—lung cancer	7.56e-05	7.56e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—HRAS—lung cancer	7.55e-05	7.55e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—KRAS—lung cancer	7.49e-05	7.49e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—KRAS—lung cancer	7.37e-05	7.37e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—PIK3CA—lung cancer	7.37e-05	7.37e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—SRC—lung cancer	7.35e-05	7.35e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—MAPK3—lung cancer	7.29e-05	7.29e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—IL6—lung cancer	7.23e-05	7.23e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—VEGFA—lung cancer	7.16e-05	7.16e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—TP53—lung cancer	7.13e-05	7.13e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—MYC—lung cancer	7.09e-05	7.09e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—STAT3—lung cancer	7.09e-05	7.09e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—NRAS—lung cancer	7.07e-05	7.07e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—EGFR—lung cancer	6.93e-05	6.93e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—PIK3CA—lung cancer	6.88e-05	6.88e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—HRAS—lung cancer	6.82e-05	6.82e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—PIK3CA—lung cancer	6.77e-05	6.77e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—MAPK3—lung cancer	6.77e-05	6.77e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—AKT1—lung cancer	6.72e-05	6.72e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PIK3CA—lung cancer	6.68e-05	6.68e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—AKT1—lung cancer	6.67e-05	6.67e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—TP53—lung cancer	6.66e-05	6.66e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—MYC—lung cancer	6.58e-05	6.58e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—TP53—lung cancer	6.55e-05	6.55e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—KRAS—lung cancer	6.55e-05	6.55e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—IL6—lung cancer	6.52e-05	6.52e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—EGFR—lung cancer	6.44e-05	6.44e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—HRAS—lung cancer	6.37e-05	6.37e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—HRAS—lung cancer	6.27e-05	6.27e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—IL6—lung cancer	6.09e-05	6.09e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—KRAS—lung cancer	6.08e-05	6.08e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—AKT1—lung cancer	6.02e-05	6.02e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PIK3CA—lung cancer	6.02e-05	6.02e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—IL6—lung cancer	6e-05	6e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—TP53—lung cancer	5.82e-05	5.82e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—AKT1—lung cancer	5.62e-05	5.62e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PIK3CA—lung cancer	5.59e-05	5.59e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—HRAS—lung cancer	5.57e-05	5.57e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—AKT1—lung cancer	5.53e-05	5.53e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—AKT1—lung cancer	5.46e-05	5.46e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—TP53—lung cancer	5.41e-05	5.41e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—IL6—lung cancer	5.33e-05	5.33e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—HRAS—lung cancer	5.17e-05	5.17e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—IL6—lung cancer	4.95e-05	4.95e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—AKT1—lung cancer	4.91e-05	4.91e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—AKT1—lung cancer	4.57e-05	4.57e-05	CbGpPWpGaD
